CD8A and colorectal cancer: Limagne et al. have shown that trifluridine/tipiracil and oxaliplatin when used in combination, ICD and antitumor CD8 activation, as well as depletion of Tumour-Associated Macrophages (TAM), in particular, TAM2, significantly were induced in MSS colorectal cancer [217].